Abstract:BACKGROUND: Paclitaxel (PTX) is a first-line chemotherapeutic drug for the treatment of prostate cancer. However, most patients develop resistance and metastasis, and thus new therapeutic approaches are urgently required. Recent studies have identified widespread anti-tumor effects of zinc (Zn) in various tumor cell lines, especially prostate cancer cells. In this study, we examined the effects of Zn as an adjuvant to PTX in prostate cancer cells.METHODS: PC3 and DU145 cells were treated with different concentrations of Zn and/or PTX. MTT assay was used to detect cell viability. Real-time cell analysis (RTCA) and microscopy were used to observe morphological changes in cells. Western blotting was used to detect the expression of epithelial-mesenchymal transition (EMT)-related proteins. qPCR (reverse transcription-polymerase chain reaction) was used to examine changes in TWIST1 mRNA levels. Cell invasion and migration were detected by scratch and transwell assays. shRNA against TWIST1 was used to knockdown TWIST1. Colony formation assay was used to detect cell proliferation, while Annexin V and propidium iodide (PI) staining was used to detect cell apoptosis.RESULTS: Zn and PTX increased proliferation inhibition in a dose- and time-dependent manner in prostate cancer cells, while Zn increased prostate cancer cell chemosensitivity to PTX. Combined Zn and PTX inhibited prostate cancer cell invasion and migration by downregulating the expression of TWIST1. Furthermore, knockdown of TWIST1 increased the sensitivity of prostate cancer cells to PTX. In addition, Zn and PTX reduced cell proliferation and induced apoptosis in prostate cancer cells.CONCLUSIONS: Our results demonstrated that Zn and PTX combined therapy inhibits EMT by reducing the expression of TWIST1, which reduces the invasion and migration of prostate cancer cells. SiTWIST1 increased the sensitivity of prostate cancer cells to PTX. In addition, with prolonged treatment, Zn and PTX inhibited proliferation and led to prostate cancer cell apoptosis. Therefore, Zn may be a potential adjuvant of PTX in treating prostate cancer and combined treatment may offer a promising therapeutic strategy for prostate cancer.

Effect Of Zinc On Prostatic Tumorigenicity In Nude Mice

Effect of Interactions Between EGCG and Zn2+ on the Growth of Prostate Cancer PC-3 Cells

Effect of Zinc on Human Prostatic Carcinoma Cell Growth

Effects Of Long-Term Exposure To Zinc Oxide Nanoparticles On Development, Zinc Metabolism And Biodistribution Of Minerals (Zn, Fe, Cu, Mn) In Mice

Long-term zinc treatment alters the mechanical properties and metabolism of prostate cancer cells

Zinc blocks gene expression of mitochondrial aconitase in human prostatic carcinoma cells

Zinc Deficiency Promotes Testicular Cell Apoptosis in Mice

Effects of Exogenous Zinc on Cell Cycle, Apoptosis and Viability of MDAMB231, HepG2 and 293 T Cells

Zinc induces a bell-shaped proliferative dose-response effect in cultured smooth muscle cells from benign prostatic hyperplasia

Molecular Insights into the Breast and Prostate Cancer Cells in Response to the Change of Extracellular Zinc

Zinc promotes prostate cancer cell chemosensitivity to paclitaxel by inhibiting epithelial‐mesenchymal transition and inducing apoptosis

Human prostate cancer ZIP1/zinc/citrate genetic/metabolic relationship in the TRAMP prostate cancer animal model

Effects of Different Zinc Species on Cellar Zinc Distribution, Cell Cycle, Apoptosis and Viability in Mdamb231 Cells

Zinc Enhances Chemosensitivity to Paclitaxel in PC‑3 Prostate Cancer Cells.

Advances of Zinc Signaling Studies in Prostate Cancer

Comparative Cytotoxicity induced by Zinc Oxide Nanoparticles in Human Prostate Cells.

Effect of different levels of dietary zinc on longevity of BALB/c mice inoculated with plasmacytoma MOPC 104E

Effects Of Exogenous Zinc On The Cellular Zinc Distribution And Cell Cycle Of A549 Cells

Zinc as a possible preventive and therapeutic agent in pancreatic, prostate, and breast cancer.

Zinc Supplementation Reduces Testicular Cell Apoptosis in Mice and Improves Spermatogenic Dysfunction Caused by Marginal Zinc Deficiency

Zinc accumulation in N-methyl-N-nitrosourea-induced rat mammary tumors is accompanied by an altered expression of ZnT-1 and metallothionein